Comparison Between Lamivudine and Entecavir Treatment in Spontaneous Severe Acute Exacerbation (NUC115132)

This study has been terminated.
(Slow progress in recruiting study patients)
Sponsor:
Collaborator:
GlaxoSmithKline
Information provided by (Responsible Party):
Sheng-Shun Yang, Taichung Veterans General Hospital
ClinicalTrials.gov Identifier:
NCT01627223
First received: June 18, 2012
Last updated: April 22, 2016
Last verified: April 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: April 2016
  Primary Completion Date: April 2016 (Final data collection date for primary outcome measure)